Medicofarma Biotech SA (WSE:MDB)

Market Cap	32.22M +42.8%
Revenue (ttm)	281.45K -73.6%
Net Income	-3.06M
EPS	-0.04
Shares Out	67.98M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	40,693
Average Volume	63,201
Open	0.4620
Previous Close	0.4770
Day's Range	0.4500 - 0.4770
52-Week Range	0.2310 - 1.4000
Beta	1.35
RSI	49.26
Earnings Date	Feb 6, 2026

About Medicofarma Biotech

Medicofarma Biotech SA engages in the research and development of medicines, medicinal products, and biotechnology products in Poland. The company offers staff support and equipment during the early stages of development of generic pharmaceutical products and cosmetics, as well as analytical examinations. It also provides MediPAN COVID SARS-CoV-2 test, a screening test for detecting the SARS-CoV-2 virus; and real-time PCR genetic tests. The company was formerly known as Inbook Spólka Akcyjna and changed its name to Medicofarma Biotech SA in Feb...

• Industry: Biotechnology & Medical Research
• Sector: Healthcare
• Founded: 2001
• Employees: 6
• Stock Exchange: Warsaw Stock Exchange
• Ticker Symbol: MDB

Financial Performance

In 2024, Medicofarma Biotech's revenue was 1.22 million, an increase of 63.14% compared to the previous year's 750,809. Losses were -2.30 million, -33.11% less than in 2023.